Free Order - District Court of Delaware - Delaware


File Size: 17.8 kB
Pages: 2
Date: May 28, 2008
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 337 Words, 2,293 Characters
Page Size: 614 x 1008 pts
URL

https://www.findforms.com/pdf_files/ded/39973/18.pdf

Download Order - District Court of Delaware ( 17.8 kB)


Preview Order - District Court of Delaware
Case 1:08-cv-00164-JJF Document 18 Filed 05/28/2008 Page 1 of 2
IN THE UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
PFIZER INC., PFIZER IRELAND :
PHARMACEUTICALS, WARNER—LAMBERT :
COMPANY, WARNER—LAMBERT COMPANY, :
LLC and WARNER—LAMBERT EXPORT LTD.,:
Plaintiffs, :
v. : Civil Action No. 08-162-JJF
RANBAXY LABORATORIES LIMITED, :
RANBAXY PHARMACEUTICALS, INC. and :
RANBAXY INC., :
Defendants. :
PFIZER INC., PFIZER IRELAND :
PHARMACEUTICALS, WARNER—LAMBERT :
COMPANY, WARNER—LAMBERT COMPANY, :
LLC and WARNER—LAMBERT EXPORT LTD.,:
Plaintiffs, :
v. : Civil Action No. 08—l64—JJF
RANBAXY LABORATORIES LIMITED, :
RANBAXY PHARMACEUTICALS, INC. and :
RANBAXY INC., :
Defendants. :
ORDER
WHEREAS, the parties have proposed a Stipulated
Briefing Schedule (D.I. 14) on Ranbaxy’s Motion to Dismiss
Pfizer’s Complaint filed on April 14, 2008 (D.I. 6);
WHEREAS, the Stipulation also indicates that resolution
of Ranbaxy’s Motion to Dismiss Pfizer’s Complaint requires
jurisdictional discovery to occur over the next two months;
NOW THEREFORE IT IS HEREBY ORDERED that:

Case 1:08-cv-00164-JJF Document 18 Filed 05/28/2008 Page 2 of 2
1. For administrative purposes, Ranbaxy’s Motion to
Dismiss Pfizer’s Complaint (D.I. 6)is DENIED with
leave to renew following the completion of
jurisdictional discovery on July 21, 2008.
2. Upon renewal of Ranbaxy’s Motion to Dismiss
Pfizer’s Complaint (D.I. 6), the briefing schedule
will be as provided by the parties in their
Stipulated Briefing Schedule: Pfizer's Answering
Brief in Opposition to Ranbaxy's Motion shall be
filed by August 8, 2008, and Ranbaxy’s Reply Brief
shall be filed by August 22, 2008. However,
should Ranbaxy assert the need for limited
discovery of Pfizer on the issue of subject matter
jurisdiction based on issues raised in Pfizer’s
Brief in Opposition, the parties will work to
agree on a schedule for such discovery and a
revised schedule for Ranbaxy’s Reply Brief.
May 28, 2008 %pq2§% E,<‘·•s¤
DATE UNI D ATES ISTRICT JUDGE '

Case 1:08-cv-00164-JJF

Document 18

Filed 05/28/2008

Page 1 of 2

Case 1:08-cv-00164-JJF

Document 18

Filed 05/28/2008

Page 2 of 2